Clinical Trial Update: A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

View source ↗

Summary

Ipsen is conducting a long-term safety and effectiveness study of palovarotene in people with fibrodysplasia ossificans progressiva; the trial is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrodysplasia Ossificans Progressiva

Drugs mentioned

• Palovarotene (palovarotene)

Snippet

Sponsor: Ipsen | Conditions: Fibrodysplasia Ossificans Progressiva | Status: RECRUITING